Iron Toxicity in Diseases of Aging: Alzheimer's Disease, Parkinson's Disease and Atherosclerosis
The DOI matches its Crossref record; 190 of the 190 references it cites were found in a registry or an index.
Abstract
Excess free iron generates oxidative stress that hallmarks diseases of aging. The observation that patients with Alzheimer's disease or Parkinson's disease show a dramatic increase in their brain iron content has opened the possibility that disturbances in brain iron homeostasis may contribute to the pathogenesis of these disorders. While the reason for iron accumulation is unknown, iron localization correlates with the production of reactive oxygen species in those areas of the brain that are prone to neurodegeneration. A role for iron is also proposed in atherosclerosis, a further frequent disorder of aging. We will review experimental evidences for an involvement of iron in these diseases and discuss some mouse models with impairment in iron-related genes that may be useful to study the role of iron in these disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Iron chelation improves endothelial function”
From Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples (2010) · cites this paper as Altamura and Muckenthaler 2009
In the citing paper
“Excessive amounts of total iron will decrease furin activity because transcription of furin is modulated by cellular concentrations of iron, leading to decreased furin protein concentrations which thereby favours β secretase activity and enhances the amyloidogenic pathway.”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [78]
In the citing paper
“By contrast, iron deficiency will increase furin activity, thereby enhancing α secretase and stimulating the non-amyloidogenic pathway.78,80”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [78]
In the citing paper
“APP translation might therefore be up-regulated in conditions of iron excess, increasing the amount of APP available to enter the amyloidgenic pathway, which is favoured by decreased furin activity.78”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [78]
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630 · cited 1×
“Atherosclerosis can be initiated by the injury of endothelial cells of the arterial wall that leads to enhanced permeability [121].”
BackgroundMutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Primate models of movement disorders of basal ganglia origin
DeLong, M. R. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90110-v · Cited by 3,824
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion
Campuzano, V., Montermini, L., Moltò, M. D., Pianese, L., Cossée, M., Cavalcanti, F., Monros, E., Rodius, F., Duclos, F., Monticelli, A., et al. (1996) · Science · doi:10.1126/science.271.5254.1423 · Cited by 2,786 · cited 1×
“In 96% of cases, it is caused by a GAA nucleotide repeat expansion inside the first intron of the frataxin gene resulting in reduced frataxin mRNA expression [183].”
BackgroundHentze, M. W., Muckenthaler, M. U., & Andrews, N. C. (2004) · Cell · doi:10.1016/s0092-8674(04)00343-5 · Cited by 1,736
Self-citationUber eine eigenartige Erkrankung der Hirnrinde
Alzheimer, A. (1907) · Medical Entomology and Zoology · Cited by 1,503
Halliwell, B. (2001) · Drugs & Aging · doi:10.2165/00002512-200118090-00004 · Cited by 1,502
Alpha-synuclein and neurodegenerative diseases
Goedert, M. (2001) · Nature Reviews Neuroscience · doi:10.1038/35081564 · Cited by 1,408 · cited 1×
“Lewy bodies form in dopaminergic neurons, axons, and synapses of the substantia nigra (SN) and are mainly composed of αsynuclein [76].”
BackgroundIron accumulation in Alzheimer disease is a source of redox-generated free radicals
Smith, M. A., Harris, P. L. R., Sayre, L. M., & Perry, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9866 · Cited by 1,355 · cited 6×
“was also observed in neurons with NFT [38].”
InfluentialIwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., Rohan de Silva, H. A., Kittel, A., & Saitoh, T. (1995) · Neuron · doi:10.1016/0896-6273(95)90302-x · Cited by 1,316 · cited 1×
“The biological function of synuclein is still under investigation but, since it localizes in the cytosol of the presynaptic terminal in close proximity to synaptic vesicles, it has been proposed to be involved in the modulation of neurotransmitter release [82,83].”
BackgroundSalonen, J. T., Nyyssönen, K., Korpela, H., Tuomilehto, J., Seppänen, R., & Salonen, R. (1992) · Circulation · doi:10.1161/01.cir.86.3.803 · Cited by 1,284 · cited 4×
“Furthermore, high ferritin levels correlate with high level of cholesterol LDL [131,132].”
BackgroundInfluentialThe iron exporter ferroportin/Slc40a1 is essential for iron homeostasis
Donovan, A., Lima, C. A., Pinkus, J. L., Pinkus, G. S., Zon, L. I., Robine, S., & Andrews, N. C. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.01.003 · Cited by 1,275 · cited 10×
“This is explained by inappropriately low hepcidin levels in hereditary hemochromatosis and the resulting expression increase of FPN that exports iron from macrophages [147].”
InfluentialNicolas, G., Bennoun, M., Devaux, I., Beaumont, C., Grandchamp, B., Kahn, A., & Vaulont, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151179498 · Cited by 1,233 · cited 3×
“Recent studies investigating different aspects of cellular and systemic iron homeostasis in the periphery have utilized mouse models with specific ablations in genes involved in intestinal iron absorption (e.g., mice with DMT-1 [164], dcytb [165] or hephaestin [166] deficiencies), cellular iron uptake (e.g., Tf [167]…”
BackgroundRegulation of ferritin genes and protein
Torti, F. M., & Torti, S. V. (2002) · Blood · doi:10.1182/blood.v99.10.3505 · Cited by 1,173 · cited 1×
“Iron normally stored within ferritin clusters does not cause oxidative damage [89], but a relative shortage of ferritin and accumulation of ferrous iron can stimulate oxidative stress and oxidative damage in the dopaminergic neurons of the substantia nigra.”
BackgroundCushing, S. D., Berliner, J. A., Valente, A. J., Territo, M. C., Navab, M., Parhami, F., Gerrity, R., Schwartz, C. J., & Fogelman, A. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5134 · Cited by 1,146
Vulpe, C. D., Kuo, Y.-M., Murphy, T. L., Cowley, L., Askwith, C., Libina, N., Gitschier, J., & Anderson, G. J. (1999) · Nature Genetics · doi:10.1038/5979 · Cited by 1,084 · cited 1×
“, mice with DMT-1 [164], dcytb [165] or hephaestin [166] deficiencies), cellular iron uptake (e.”
BackgroundRitchie, C. W., Bush, A. I., Mackinnon, A., Macfarlane, S., Mastwyk, M., MacGregor, L., Kiers, L., Cherny, R., Li, Q.-X., Tammer, A., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1685 · Cited by 988
IRON AND THE SEX DIFFERENCE IN HEART DISEASE RISK
Sullivan, J. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92463-6 · Cited by 969
Regulation of Mitochondrial Iron Accumulation by Yfh1p, a Putative Homolog of Frataxin
Babcock, M., de Silva, D., Oaks, R., Davis-Kaplan, S., Jiralerspong, S., Montermini, L., Pandolfo, M., & Kaplan, J. (1997) · Science · doi:10.1126/science.276.5319.1709 · Cited by 921 · cited 1×
“mal controls and show increased sensitivity to oxidative stress [186,187].”
BackgroundRajavashisth, T. B., Andalibi, A., Territo, M. C., Berliner, J. A., Navab, M., Fogelman, A. M., & Lusis, A. J. (1990) · Nature · doi:10.1038/344254a0 · Cited by 776
Intramuscular desferrioxamine in patients with Alzheimer's disease
MCLACHLAN, D. (1991) · The Lancet · doi:10.1016/0140-6736(91)92978-b · Cited by 764 · cited 1×
“through phlebotomy or chelation strategies may offer a protective effect for individuals with increased risk of PD, AD, or atherosclerosis [198,199,202].”
BackgroundPuccio, H., Simon, D., Cossée, M., Criqui-Filipe, P., Tiziano, F., Melki, J., Hindelang, C., Matyas, R., Rustin, P., & Koenig, M. (2001) · Nature Genetics · doi:10.1038/84818 · Cited by 738 · cited 1×
“In this mouse line, mitochondria seem unusually swollen and abnormalities are observed in the respiratory chain complexes consistent with the loss of [Fe-S] protein activities [196].”
BackgroundMuckenthaler, M. U., Galy, B., & Hentze, M. W. (2008) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.28.061807.155521 · Cited by 701 · cited 1×
“In the case of transferrin receptor 1 mRNA, IRP binding to the 3’ UTR regulates mRNA stability [2].”
BackgroundSelf-citationAtwood, C. S., Scarpa, R. C., Huang, X., Moir, R. D., Jones, W. D., Fairlie, D. P., Tanzi, R. E., & Bush, A. I. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751219.x · Cited by 641
Barrow, C. J., Yasuda, A., Kenny, P. T. M., & Zagorski, M. G. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90106-t · Cited by 635 · cited 1×
“metal ions Aβ is unable to aggregate [44,45].”
BackgroundSELKOE, D. J. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05554.x · Cited by 630
Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo
Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J. Q., Boonplueang, R., Viswanath, V., Jacobs, R., Yang, L., Beal, M. F., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00126-0 · Cited by 620 · cited 1×
“, H-ferritin deficient and overexpressing mice [113,175]).”
Transferrin receptor is necessary for development of erythrocytes and the nervous system
Levy, J. E., Jin, O., Fujiwara, Y., Kuo, F., & Andrews, N. (1999) · Nature Genetics · doi:10.1038/7727 · Cited by 574 · cited 4×
“Recent studies investigating different aspects of cellular and systemic iron homeostasis in the periphery have utilized mouse models with specific ablations in genes involved in intestinal iron absorption (e.g., mice with DMT-1 [164], dcytb [165] or hephaestin [166] deficiencies), cellular iron uptake (e.g., Tf [167]…”
BackgroundInfluentialTargeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux
Harris, Z. L., Durley, A. P., Man, T. K., & Gitlin, J. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10812 · Cited by 568 · cited 1×
“, FPN [173] or ceruloplasmin [174] knock-out”
Rogers, J. T., Randall, J. D., Cahill, C. M., Eder, P. S., Huang, X., Gunshin, H., Leiter, L., McPhee, J., Sarang, S. S., Utsuki, T., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207435200 · Cited by 551 · cited 1×
“tions and confers reduced AβPP expression [49].”
Curtis, A. R. J., Fey, C., Morris, C. M., Bindoff, L. A., Ince, P. G., Chinnery, P. F., Coulthard, A., Jackson, M. J., Jackson, A. P., McHale, D. P., et al. (2001) · Nature Genetics · doi:10.1038/ng571 · Cited by 537 · cited 1×
“The neuroprotective role of ferritin is most directly evident from the neurodegenerative disorder “neuroferritinopathy” [111], in which insertion of an adenine within the region that encodes the C-terminus of the ferritin L-chain affects the basal ganglia and is associated with profound iron accumulations.”
BackgroundSolution Structures of β Peptide and Its Constituent Fragments: Relation to Amyloid Deposition
Barrow, C. J., & Zagorski, M. G. (1991) · Science · doi:10.1126/science.1853202 · Cited by 537 · cited 1×
“metal ions Aβ is unable to aggregate [44,45].”
BackgroundHeinecke, J. W., Rosen, H., & Chait, A. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111609 · Cited by 536 · cited 1×
“Ironand/or copper-catalyzed free radical production may contribute to the oxidative modification of LDL either in the plasma [149] or the interior of advanced human atherosclerotic lesions that indeed contain reductionoxidation active iron and copper [150–153].”
BackgroundHFE gene knockout produces mouse model of hereditary hemochromatosis
Zhou, X. Y., Tomatsu, S., Fleming, R. E., Parkkila, S., Waheed, A., Jiang, J., Fei, Y., Brunt, E. M., Ruddy, D. A., Prass, C. E., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2492 · Cited by 521 · cited 16×
“Analysis of 328 patients with sporadic AD has shown that the H63D HFE mutant allele together with the ApoEε4 allele significantly reduces age of onset of AD compared to ApoEε4 carriers alone [56].”
BackgroundInfluentialPhysiology and Anatomy of Possible Oscillators in the Central Nervous System
Rothwell, J. C. (2008) · Movement Disorders · doi:10.1002/mds.870131304 · Cited by 511
LaVaute, T., Smith, S., Cooperman, S., Iwai, K., Land, W., Meyron-Holtz, E., Drake, S. K., Miller, G., Abu-Asab, M., Tsokos, M., et al. (2001) · Nature Genetics · doi:10.1038/84859 · Cited by 509 · cited 2×
“‘functional iron deficiency’ in the brain that promotes neuronal damage [114].”
BackgroundGerlach, M., & Riederer, P. (1996) · Journal of Neural Transmission · doi:10.1007/bf01291788 · Cited by 498
Zecca, L., Stroppolo, A., Gatti, A., Tampellini, D., Toscani, M., Gallorini, M., Giaveri, G., Arosio, P., Santambrogio, P., Fariello, R. G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403495101 · Cited by 495 · cited 1×
“Within the SN, NM is detected after the first year of life and its concentration increases with age [116].”
BackgroundGood, P. F., Perl, D. P., Bierer, L. M., & Schmeidler, J. (1992) · Annals of Neurology · doi:10.1002/ana.410310310 · Cited by 476
Identification of the receptor scavenging hemopexin-heme complexes
Hvidberg, V., Maniecki, M. B., Jacobsen, C., Højrup, P., Møller, H. J., & Moestrup, S. K. (2005) · Blood · doi:10.1182/blood-2005-03-1185 · Cited by 473 · cited 1×
“CD91 is expressed in several cell types including macrophages [159].”
BackgroundFeder, J. N., Tsuchihashi, Z., Irrinki, A., Lee, V. K., Mapa, F. A., Morikang, E., Prass, C. E., Starnes, S. M., Wolff, R. K., Parkkila, S., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.22.14025 · Cited by 471 · cited 1×
“In particular, homozygous C282Y mutations cause severe iron overload due to the disruption of a disulfide bridge in the HFE α3 domain that leads to a loss of β-2 microglobulin binding and a lack of HFE cell surface expression [63].”
BackgroundThe A53T α-Synuclein Mutation Increases Iron-Dependent Aggregation and Toxicity
Ostrerova-Golts, N., Petrucelli, L., Hardy, J., Lee, J. M., Farer, M., & Wolozin, B. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06048.2000 · Cited by 466
The combined role of P- and E-selectins in atherosclerosis.
Dong, Z. M., Chapman, S. M., Brown, A. A., Frenette, P. S., Hynes, R. O., & Wagner, D. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3001 · Cited by 459 · cited 1×
“As a consequence, monocytes are recruited to the vascular endothelium, infiltrate the subendothelial space [125] attracted by chemoattrac-”
BackgroundSmith, C., Mitchinson, M. J., Aruoma, O. I., & Halliwell, B. (1992) · Biochemical Journal · doi:10.1042/bj2860901 · Cited by 455
Oxidative stress induces amyloid-like aggregate formation of NACP/α-synuclein in vitro
Hashimoto, M., Hsu, L. J., Xia, Y., Takeda, A., Sisk, A., Sundsmo, M., & Masliah, E. (1999) · NeuroReport · doi:10.1097/00001756-199903170-00011 · Cited by 429
Gunshin, H., Fujiwara, Y., Custodio, A. O., DiRenzo, C., Robine, S., & Andrews, N. C. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24356 · Cited by 419 · cited 2×
“Recent studies investigating different aspects of cellular and systemic iron homeostasis in the periphery have utilized mouse models with specific ablations in genes involved in intestinal iron absorption (e.g., mice with DMT-1 [164], dcytb [165] or hephaestin [166] deficiencies), cellular iron uptake (e.g., Tf [167]…”
BackgroundImmunohistochemical evidence of oxidative [corrected] stress in Alzheimer's disease.
Pappolla, M. A., Omar, R. A., Kim, K. S., & Robakis, N. K. R. K. (1992) · PubMed Central · Cited by 415
Meyron‐Holtz, E. G., Ghosh, M. C., Iwai, K., LaVaute, T., Brazzolotto, X., Berger, U. V., Land, W., Ollivierre‐Wilson, H., Grinberg, A., Love, P., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600041 · Cited by 408 · cited 1×
“While mice with a constitutive deletion of IRP-1 are healthy [178,179], mice with disruption of IRP-2 show a neurodegenerative disease characterized by a movement disorder with ataxia, bradikinesia, and tremor.”
BackgroundRole of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice.
Qiao, J. H., Tripathi, J., Mishra, N. K., Cai, Y., Tripathi, S., Wang, X. P., Imes, S., Fishbein, M. C., Clinton, S. K., Libby, P., et al. (1997) · Europe PMC (PubMed Central) · Cited by 396
Seidah, N. G., Chrétien, M., & Day, R. (1994) · Biochimie · doi:10.1016/0300-9084(94)90147-3 · Cited by 396 · cited 1×
“proteins into their biologically active form [46].”
Receptor-mediated Transcytosis of Lactoferrin through the Blood-Brain Barrier
Fillebeen, C., Descamps, L., Dehouck, M.-P., Fenart, L., Benaı̈ssa, M., Spik, G., Cecchelli, R., & Pierce, A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.11.7011 · Cited by 385
Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury
Patel, B. N., Dunn, R. J., Jeong, S. Y., Zhu, Q., Julien, J.-P., & David, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06578.2002 · Cited by 379 · cited 1×
“Consistent with these observations, CP−/− mice showed a loss of dopaminergic neurons within the brainstem that may explain the deficit in motor coordination [182].”
Foury, F., & Cazzalini, O. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00734-5 · Cited by 378 · cited 1×
“mal controls and show increased sensitivity to oxidative stress [186,187].”
BackgroundJeong, S. Y., & David, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301988200 · Cited by 377
Cossee, M. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.8.1219 · Cited by 377
Drüeke, T., Witko-Sarsat, V., Massy, Z., Descamps-Latscha, B., Guerin, A. P., Marchais, S. J., Gausson, V., & London, G. M. (2002) · Circulation · doi:10.1161/01.cir.0000035250.66458.67 · Cited by 376 · cited 1×
“In dialysis patients, the massive intravenous iron treatment correlates with the production of advanced oxidation protein products and with carotid intima media thickness, an early marker of the atherosclerotic process [162,163].”
BackgroundConnor, J. R., Snyder, B. S., Beard, J. L., Fine, R. E., & Mufson, E. J. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490310214 · Cited by 374
A mouse model of juvenile hemochromatosis
Huang, F. W. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25049 · Cited by 365 · cited 5×
“, HFE [169], TfR2 [170], HJV [171], or Hepcidin [172] -deficient mice), cellular iron ex-”
BackgroundInfluentialDe Domenico, I., Ward, D. M., di Patti, M. C. B., Jeong, S. Y., David, S., Musci, G., & Kaplan, J. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601735 · Cited by 350 · cited 1×
“GPI-linked ceruloplasmin may additionally stabilize the FPN protein since in the absence of GPI-linked ceruloplasmin, FPN is internalized and degraded in a C6 glioma cell line [14].”
BackgroundThe Relevance of Iron in the Pathogenesis of Parkinson's Disease
GÖTZ, M. E., DOUBLE, K., GERLACH, M., YOUDIM, M. B. H., & RIEDERERE, P. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.017 · Cited by 342
Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia
Bradley, J. L. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.2.275 · Cited by 339 · cited 1×
“Frataxin is localized within the mitochondria [184] and the mitochondrial iron content is increased in Friedreich’s ataxia patients [185].”
BackgroundIron deficiency decreases dopamine D1 and D2 receptors in rat brain
Erikson, K. M., Jones, B. C., Hess, E. J., Zhang, Q., & Beard, J. L. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00563-9 · Cited by 335 · cited 1×
“Irondeficient rats show increased extracellular dopamine and noradrenaline and a decrease of dopamine D1 and D2 receptors [25].”
BackgroundThe yeast frataxin homolog Yfh1p plays a specific role in the maturation of cellular Fe/S proteins
Muhlenhoff, U. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.17.2025 · Cited by 326
Connor, J. R., Snyder, B. S., Arosio, P., Loeffler, D. A., & LeWitt, P. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65020717.x · Cited by 317 · cited 1×
“In line with the proposed role of iron in neuronal damage in PD, increased free iron and decreased ferritin levels have been found in the substantia nigra in postmortem brain tissues from PD patients [90,108, 109] (Fig.”
BackgroundFurin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis
Silvestri, L., Pagani, A., & Camaschella, C. (2008) · Blood · doi:10.1182/blood-2007-07-100677 · Cited by 311 · cited 5×
“Recent studies investigating different aspects of cellular and systemic iron homeostasis in the periphery have utilized mouse models with specific ablations in genes involved in intestinal iron absorption (e.g., mice with DMT-1 [164], dcytb [165] or hephaestin [166] deficiencies), cellular iron uptake (e.g., Tf [167]…”
InfluentialStadler, N., Lindner, R. A., & Davies, M. J. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000124892.90999.cb · Cited by 310
House, E., Collingwood, J., Khan, A., Korchazkina, O., Berthon, G., & Exley, C. (2004) · Journal of Alzheimer's Disease · doi:10.3233/jad-2004-6310 · Cited by 294 · cited 1×
“promotes Aβ aggregation [42,43] and in the absence of”
BackgroundIron‐Melanin Interaction and Lipid Peroxidation: Implications for Parkinson's Disease
Ben‐Shachar, D., Riederer, P., & Youdim, M. B. H. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb06358.x · Cited by 287 · cited 1×
“Moreover, intracerebroventricular injection of the iron chelator desferrioxamine has been shown to retard 6-hydroxydopamine-induced degeneration of nigrostriatal neurons [104].”
BackgroundZecca, L., Fariello, R., Riederer, P., Sulzer, D., Gatti, A., & Tampellini, D. (2002) · FEBS Letters · doi:10.1016/s0014-5793(01)03269-0 · Cited by 285 · cited 1×
“Interestingly, within the SN of PD patients, NM levels are reduced by half [119] and the corresponding redox activity is significantly elevated.”
BackgroundThe Yeast Frataxin Homologue Mediates Mitochondrial Iron Efflux
Radisky, D. C., Babcock, M. C., & Kaplan, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.4497 · Cited by 277 · cited 1×
“activity of mitochondrial [Fe-S] cluster enzymes and impaired mitochondrial respiration [191,192].”
BackgroundEarly Embryonic Lethality of H Ferritin Gene Deletion in Mice
Ferreira, C., Bucchini, D., Martin, M.-E., Levi, S., Arosio, P., Grandchamp, B., & Beaumont, C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.5.3021 · Cited by 276 · cited 1×
“, H-ferritin deficient and overexpressing mice [113,175]).”
Lin, L., Valore, E. V., Nemeth, E., Goodnough, J. B., Gabayan, V., & Ganz, T. (2007) · Blood · doi:10.1182/blood-2007-04-087593 · Cited by 267 · cited 1×
“It also regulates expression of the liver-expressed peptide hormone hepcidin (Hamp1/Leap1) that coordinates systemic iron fluxes [3].”
BackgroundSequestration of iron by Lewy bodies in Parkinson's disease
Castellani, R. J., Siedlak, S. L., Perry, G., & Smith, M. A. (2000) · Acta Neuropathologica · doi:10.1007/s004010050001 · Cited by 265 · cited 1×
“[87] have shown that the excess iron found”
BackgroundDecreased ferritin levels in brain in Parkinson's disease
Dexter, D. T., Carayon, A., Vidailhet, M., Ruberg, M., Agid, F., Agid, Y., Lees, A. J., Wells, F. R., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb08814.x · Cited by 258 · cited 1×
“In line with the proposed role of iron in neuronal damage in PD, increased free iron and decreased ferritin levels have been found in the substantia nigra in postmortem brain tissues from PD patients [90,108, 109] (Fig.”
BackgroundComplex I, iron, and ferritin in Parkinson's disease substantia nigra
Mann, V. M., Cooper, J. M., Daniel, S. E., Srai, K., Jenner, P., Marsden, C. D., & Schapira, A. H. V. (1994) · Annals of Neurology · doi:10.1002/ana.410360612 · Cited by 251 · cited 1×
“In line with the proposed role of iron in neuronal damage in PD, increased free iron and decreased ferritin levels have been found in the substantia nigra in postmortem brain tissues from PD patients [90,108, 109] (Fig.”
BackgroundYamamoto, A., Shin, R., Hasegawa, K., Naiki, H., Sato, H., Yoshimasu, F., & Kitamoto, T. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01061.x · Cited by 246
Shachar, D. B., Kahana, N., Kampel, V., Warshawsky, A., & Youdim, M. B. H. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.09.005 · Cited by 246
Roest, M., van der Schouw, Y. T., de Valk, B., Marx, J. J. M., Tempelman, M. J., de Groot, P. G., Sixma, J. J., & Banga, J. D. (1999) · Circulation · doi:10.1161/01.cir.100.12.1268 · Cited by 245 · cited 1×
“atherosclerosis-related mortality if complicating factors such as hypertension and smoking existed [140].”
BackgroundAl-Mahdawi, S., Pinto, R. M., Varshney, D., Lawrence, L., Lowrie, M. B., Hughes, S., Webster, Z., Blake, J., Cooper, J. M., King, R., et al. (2006) · Genomics · doi:10.1016/j.ygeno.2006.06.015 · Cited by 243 · cited 1×
“Similar data were reported from a study of human frataxin YAC transgenic mice that contain the typical GAA repeat expansion observed in Friedreich’s ataxia patients [197].”
ResultBrain iron metabolism: Neurobiology and neurochemistry
Ke, Y., & Qian, Z. M. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.07.009 · Cited by 236 · cited 1×
“Transferrin- and non-transferrinbound iron are taken up by neurons, astrocytes, and oligodendrocytes [18].”
BackgroundTuomainen, T.-P., Kontula, K., Nyyssönen, K., Lakka, T. A., Heliö, T., & Salonen, J. T. (1999) · Circulation · doi:10.1161/01.cir.100.12.1274 · Cited by 232 · cited 1×
“These data were confirmed in 1,150 Finnish men, whereby C282Y heterozygosity increased the risk for first acute myocardial infarction two-fold [141].”
ResultMünch, G., Lüth, H. J., Wong, A., Arendt, T., Hirsch, E., Ravid, R., & Riederer, P. (2000) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(00)00096-x · Cited by 231
Faucheux, B. A., Martin, M., Beaumont, C., Hauw, J., Agid, Y., & Hirsch, E. C. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01923.x · Cited by 229 · cited 1×
“This suggests that the amount of NM in PD is not sufficient to compensate for the increase of iron loading in the PD brain and, as a consequence, free radicals may arise causing neuronal toxicity [120].”
BackgroundMagnesium Inhibits Spontaneous and Iron-induced Aggregation of α-Synuclein
Golts, N., Snyder, H., Frasier, M., Theisler, C., Choi, P., & Wolozin, B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107866200 · Cited by 214
Bernstein, S. E. (1987) · PubMed · Cited by 212
Hemochromatosis: An endocrine liver disease
Pietrangelo, A. (2007) · Hepatology · doi:10.1002/hep.21886 · Cited by 212
Expression of the iron transporter ferroportin in synaptic vesicles and the blood-brain barrier
Wu, L. J.-C., Leenders, A. G. M., Cooperman, S., Meyron-Holtz, E., Smith, S., Land, W., Tsai, R. Y. L., Berger, U. V., Sheng, Z.-H., & Rouault, T. A. (2004) · Brain Research · doi:10.1016/j.brainres.2003.10.066 · Cited by 210 · cited 2×
“Interestingly, FPN is expressed throughout the neurons and in oligodendrocytes suggesting that iron export is a permanently active mechanism in these cells [12].”
Backgroundα‐Synuclein produces a long‐lasting increase in neurotransmitter release
Liu, S., Ninan, I., Antonova, I., Battaglia, F., Trinchese, F., Narasanna, A., Kolodilov, N., Dauer, W., Hawkins, R. D., & Arancio, O. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600451 · Cited by 198 · cited 1×
“The biological function of synuclein is still under investigation but, since it localizes in the cytosol of the presynaptic terminal in close proximity to synaptic vesicles, it has been proposed to be involved in the modulation of neurotransmitter release [82,83].”
BackgroundZemlan, F. P., Thienhaus, O. J., & Bosmann, H. B. (1989) · Brain Research · doi:10.1016/0006-8993(89)91550-3 · Cited by 195
Cybrd1 (duodenal cytochrome b) is not necessary for dietary iron absorption in mice
Gunshin, H., Starr, C. N., DiRenzo, C., Fleming, M. D., Jin, J., Greer, E. L., Sellers, V. M., Galica, S. M., & Andrews, N. C. (2005) · Blood · doi:10.1182/blood-2005-02-0716 · Cited by 188 · cited 1×
“, mice with DMT-1 [164], dcytb [165] or hephaestin [166] deficiencies), cellular iron uptake (e.”
BackgroundThree Histidine Residues of Amyloid-β Peptide Control the Redox Activity of Copper and Iron
Nakamura, M., Shishido, N., Nunomura, A., Smith, M. A., Perry, G., Hayashi, Y., Nakayama, K., & Hayashi, T. (2007) · Biochemistry · doi:10.1021/bi701079z · Cited by 182
α-synuclein implicated in Parkinson’s disease catalyses the formation of hydrogen peroxide in vitro
Turnbull, S., Tabner, B. J., El-Agnaf, O. M. A., Moore, S., Davies, Y., & Allsop, D. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00513-5 · Cited by 182
Friedlich, A. L., Tanzi, R. E., & Rogers, J. T. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001937 · Cited by 181 · cited 1×
“However, the functionality of this IRE sequence still awaits experimental proof [85].”
BackgroundMR evaluation of age-related increase of brain iron in young adult and older normal males
Bartzokis, G., Beckson, M., Hance, D. B., Marx, P., Foster, J. A., & Marder, S. R. (1997) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(96)00234-2 · Cited by 181 · cited 1×
“While brain iron levels generally increase in the aging brain [30], the observation that patients with Alzheimer’s disease (AD) or Parkinson’s disease (PD) show a dramatic increase in their brain iron content has opened the possibility that disturbances in brain iron homeostasis may contribute to the pathogenesis of t…”
BackgroundIron regulation and erythropoiesis
Nemeth, E. (2008) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3282f73335 · Cited by 181 · cited 3×
“If iron levels are low, IRP binding to the 5’UTR of FTH1 or FPN1 inhibits mRNA translation.”
BackgroundIron Overload Augments the Development of Atherosclerotic Lesions in Rabbits
Araujo, J. A., Romano, E. L., Brito, B. E., Parthé, V., Romano, M., Bracho, M., Montaño, R. F., & Cardier, J. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.8.1172 · Cited by 180 · cited 1×
“In these animals, iron is detectable within the lesion by nuclear microscopy [152, 155].”
BackgroundNormal deposition of brain iron in childhood and adolescence: MR imaging at 1.5 T.
Aoki, S., Okada, Y., Nishimura, K., Barkovich, A. J., Kjos, B. O., Brasch, R. C., & Norman, D. (1989) · Radiology · doi:10.1148/radiology.172.2.2748819 · Cited by 174 · cited 1×
“High iron concentrations are also detected in the globus pallidus, caudate nucleus, putamen, and substantia nigra [29].”
BackgroundHydroxyl Radicals, Iron, Oxidative Stress, and Neurodegenerationa
Gutteridge, J. M. C. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb21805.x · Cited by 172
Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for α-synuclein
Arawaka, S., Saito, Y., Murayama, S., & Mori, H. (1998) · Neurology · doi:10.1212/wnl.51.3.887 · Cited by 172
Neuroprotection by S ‐nitrosoglutathione of brain dopamine neurons from oxidative stress
Rauhala, P., Lin, A. M. ‐., & Chiueh, C. C. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.2.165 · Cited by 166
Park, S., Gakh, O., O'Neill, H. A., Mangravita, A., Nichol, H., Ferreira, G. C., & Isaya, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303158200 · Cited by 165 · cited 1×
“Structural studies indicate that Yfh1p multimerizes and stores more than 2,000 atoms of ferric iron [188,189].”
BackgroundFirst phenotypic description of transferrin receptor 2 knockout mouse, and the role of hepcidin
Wallace, D. F., Summerville, L., Lusby, P. E., & Subramaniam, V. N. (2005) · Gut · doi:10.1136/gut.2004.062018 · Cited by 160 · cited 3×
“Recent studies investigating different aspects of cellular and systemic iron homeostasis in the periphery have utilized mouse models with specific ablations in genes involved in intestinal iron absorption (e.g., mice with DMT-1 [164], dcytb [165] or hephaestin [166] deficiencies), cellular iron uptake (e.g., Tf [167]…”
BackgroundWang, L., Johnson, E. E., Shi, H. N., Walker, W. A., Wessling-Resnick, M., & Cherayil, B. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.4.2723 · Cited by 159 · cited 1×
“demonstrated that low macrophage iron levels attenuate the inflammatory response by reducing macrophage cytokine translation [148].”
BackgroundEffect of prenatal iron deficiency on myelination in rat pups.
Yu, G. S., Steinkirchner, T. M., Rao, G. A., & Larkin, E. C. (1986) · PubMed Central · Cited by 156
Oxidative Stress and Parkinson's Diseasea
OWEN, A. D., SCHAPIRA, A. H. V., JENNER, P., & MARSDEN, C. D. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb39064.x · Cited by 155
Possible association of a reduction in cardiovascular events with blood donation.
Meyers, D. G., Strickland, D., Maloley, P. A., Seburg, J. K., Wilson, J. E., & McManus, B. F. (1997) · Heart · doi:10.1136/hrt.78.2.188 · Cited by 148 · cited 1×
“Indeed, myocardial infarction was reduced to 86% in 2682 Finnish male blood donors [138] while coronary artery disease was reduced to 50% in an independent study population of blood donors [139].”
BackgroundJeong, S. Y., & David, S. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2922-06.2006 · Cited by 147
Moderate iron deficiency in infancy: biology and behavior in young rats
Beard, J. L., Felt, B., Schallert, T., Burhans, M., Connor, J. R., & Georgieff, M. K. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.02.024 · Cited by 146 · cited 1×
“tion at the postnatal stage is unable to correct cognitive defects that arise in utero as a consequence of iron deficiency [20]; ii) the rate of daily iron uptake into the brain is less than its requirements suggest; and iii) the brain iron content is almost unaffected in adult mice that develop severe iron deficiency…”
BackgroundSerum ferritin and risk of myocardial infarction in the elderly: the Rotterdam Study
Klipstein‐Grobusch, K., Koster, J. F., Grobbee, D. E., Lindemans, J. W., Boeing, H., Albert Hofman, D., & Witteman, J. C. M. (1999) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.6.1231 · Cited by 146 · cited 1×
“Some studies report that high ferritin levels (> 200 μg/ml), a commonly used biomarker for increased hepatic iron levels, is a risk factor for the development of coronary heart disease [129] or myocardial infarction, in particular in smokers and in subjects with diabetes or high serum cholesterol concentrations [130].”
BackgroundYou, S.-A., & Wang, Q. K. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.02.001 · Cited by 145 · cited 1×
“The results are contradictory (for an extensive review, see [128]).”
Low iron concentration and aconitase deficiency in a yeast frataxin homologue deficient strain
Foury, F. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00961-8 · Cited by 145 · cited 1×
“activity of mitochondrial [Fe-S] cluster enzymes and impaired mitochondrial respiration [191,192].”
BackgroundTuomainen, T.-P., Salonen, R., Nyyssouml;nen, K., & Salonen, J. T. (1997) · BMJ · doi:10.1136/bmj.314.7083.793 · Cited by 142
The effect of a synthetic neuromelanin on yield of free hydroxyl radicals generated in model systems
Zaręba, M., Bober, A., Korytowski, W., Zecca, L., & Sarna, T. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(95)00058-c · Cited by 140 · cited 1×
“Under physiological conditions, neuromelanin is saturated with iron to approximately 50%, suggesting that NM protects from oxidative stress via sequestering redox-active iron [117, 118].”
BackgroundA potential pathogenetic role of iron in Alzheimer's disease
Silvestri, L., & Camaschella, C. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00356.x · Cited by 138 · cited 1×
“According to a hypothesis by Silvestri and Camaschella (2008) [48], this may stimulate the non-amyloidogenic pathway, whereby furin activates the α-secretase that cleaves AβPP within the Aβ domain generating the extracellular soluble sAβPPα and the membrane bound α-carboxy terminal fragment (αCTF).”
BackgroundShima, T., Sarna, T., Swartz, H. M., Stroppolo, A., Gerbasi, R., & Zecca, L. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00623-5 · Cited by 135 · cited 1×
“Under physiological conditions, neuromelanin is saturated with iron to approximately 50%, suggesting that NM protects from oxidative stress via sequestering redox-active iron [117, 118].”
BackgroundActivation of iron regulatory protein-1 by oxidative stress in vitro
Pantopoulos, K., & Hentze, M. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10559 · Cited by 130 · cited 1×
“production activates IRP1 activity [53], increasing iron”
Physical Evidence that Yeast Frataxin Is an Iron Storage Protein
Gakh, O., Adamec, J., Gacy, A. M., Twesten, R. D., Owen, W. G., & Isaya, G. (2002) · Biochemistry · doi:10.1021/bi025566+ · Cited by 128 · cited 1×
“Structural studies indicate that Yfh1p multimerizes and stores more than 2,000 atoms of ferric iron [188,189].”
BackgroundSiddappa, A. J. M., Rao, R. B., Wobken, J. D., Leibold, E. A., Connor, J. R., & Georgieff, M. K. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10246 · Cited by 128 · cited 3×
“Several mechanisms have been proposed, including i) receptor-mediated transcytosis of iron-containing transferrin [7]; ii) release of iron from the endosome via divalent metal transporter 1 (DMT1) [8,9]; as well as iii) a role for low molecular weight molecules released from astrocytes that capture the iron once it ex…”
BackgroundIron metabolism and Parkinson's disease.
Hirsch, É. C., & Faucheux, B. A. (1998) · PubMed · Cited by 124
Dedman, D. J., Treffry, A., Candy, J. M., Taylor, G. A. A., Morris, C. M., Bloxham, C. A., Perry, R. H., Edwardson, J. A., & Harrison, P. M. (1992) · Biochemical Journal · doi:10.1042/bj2870509 · Cited by 121
Robson, K. J. H., Lehmann, D. J., Wimhurst, V. L. C., Livesey, K. J., Combrinck, M., Merryweather-Clarke, A. T., Warden, D. R., & Smith, A. D. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.015552 · Cited by 120
Copper, Zinc, and the Metallobiology of Alzheimer Disease
Bush, A. I. (2003) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200307000-00005 · Cited by 118
Faucheux, B. A., Martin, M., Beaumont, C., Hunot, S., Hauw, J., Agid, Y., & Hirsch, E. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01118.x · Cited by 116 · cited 1×
“In addition, the lack of ferritin upregulation correlates with sustained IRP-1 activity which is the predominant form of IRP in the human mesencephalon [112].”
BackgroundThe hemochromatosis gene affects the age of onset of sporadic Alzheimer’s disease
Sampietro, M., Caputo, L., Casatta, A., Meregalli, M., Pellagatti, A., Tagliabue, J., Annoni, G., & Vergani, C. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00219-6 · Cited by 115 · cited 1×
“Further analysis of 107 patients with sporadic late-onset AD suggested that the frequency of the H63D mutation was highest in the patients younger than 70 years at the time of disease onset compared to patients over 80 [59].”
BackgroundKwik-Uribe, C. L., Golub, M. S., & Keen, C. L. (2000) · Journal of Nutrition · doi:10.1093/jn/130.8.2040 · Cited by 114 · cited 1×
“tion at the postnatal stage is unable to correct cognitive defects that arise in utero as a consequence of iron deficiency [20]; ii) the rate of daily iron uptake into the brain is less than its requirements suggest; and iii) the brain iron content is almost unaffected in adult mice that develop severe iron deficiency…”
BackgroundAre hereditary hemochromatosis mutations involved in Alzheimer disease?
Moalem, S., Percy, M. E., Andrews, D. F., Kruck, T. P. A., Wong, S., Dalton, A. J., Mehta, P., Fedor, B., & Warren, A. C. (2000) · American Journal of Medical Genetics · doi:10.1002/1096-8628(20000703)93:1<58::aid-ajmg10>3.0.co;2-l · Cited by 114 · cited 1×
“These include a study of HFE mutations in 26 patients with familial AD whereby HFE mutations were overrepresented in males and underrepresented in females suggesting a protective role in women [57].”
BackgroundMoos, T., & Morgan, E. H. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02142.x · Cited by 114 · cited 5×
“There is general agreement that the brain capillary endothelial cells (BCECs) absorb ironbound transferrin from the blood via transferrin receptor 1 (TfR1)-mediated endocytosis [6].”
BackgroundInfluentialVidal, R., Miravalle, L., Gao, X., Barbeito, A. G., Baraibar, M. A., Hekmatyar, S. K., Widel, M., Bansal, N., Delisle, M. B., & Ghetti, B. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3962-07.2008 · Cited by 109 · cited 1×
“Recently, a transgenic mouse line expressing a human FTL cDNA carrying a thymidine and cytidine insertion at position 498 (FTL498-499InsTC) was generated that shows similar characteristics like patients with the corresponding mutation, including the formation of nuclear and cytoplasmic ferritin inclusion bodies [177].”
BackgroundSiddappa, A. M., Rao, R., Wobken, J. D., Casperson, K., Leibold, E. A., Connor, J. R., & Georgieff, M. (2003) · Pediatric Research · doi:10.1203/01.pdr.0000058922.67035.d5 · Cited by 108 · cited 3×
“Several mechanisms have been proposed, including i) receptor-mediated transcytosis of iron-containing transferrin [7]; ii) release of iron from the endosome via divalent metal transporter 1 (DMT1) [8,9]; as well as iii) a role for low molecular weight molecules released from astrocytes that capture the iron once it ex…”
BackgroundAssociation of transferrin C2 allele with late-onset Alzheimer's disease
Namekata, K., Imagawa, M., Terashi, A., Ohta, S., Oyama, F., & Ihara, Y. (1997) · Human Genetics · doi:10.1007/s004390050600 · Cited by 107 · cited 1×
“increased frequency in AD patients [67,68].”
Perspectives on MAO-B in Aging and Neurological Disease: Where Do We Go From Here?
Kumar, M. J., & Andersen, J. K. (2004) · Molecular Neurobiology · doi:10.1385/mn:30:1:077 · Cited by 103 · cited 1×
“Iron is also involved in the enzymatic degradation of neurotransmitters since it is a cofactor of monoamine oxidase (MAO), the enzyme responsible of oxidative deamination of dopamine, adrenaline, and noradrenaline [27].”
BackgroundMinqin, R., Rajendran, R., Pan, N., Kwong-Huat Tan, B., Ong, W.-Y., Watt, F., & Halliwell, B. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.01.008 · Cited by 100 · cited 1×
“Interestingly, treatment of the rabbits with desferrioxamine, an iron chelator, caused inhibition of atherosclerotic plaque development and decreased the iron concentration within the lesion [156,157].”
BackgroundFrataxin gene of Friedreich's ataxia is targeted to mitochondria
Priller, J., Scherzer, C. R., Faber, P. W., MacDonald, M. E., & Yong, A. B. (1997) · Annals of Neurology · doi:10.1002/ana.410420222 · Cited by 99 · cited 1×
“Frataxin is localized within the mitochondria [184] and the mitochondrial iron content is increased in Friedreich’s ataxia patients [185].”
BackgroundSangchot, P., Sharma, S., Chetsawang, B., Porter, J., Govitrapong, P., & Ebadi, M. (2002) · Developmental Neuroscience · doi:10.1159/000065700 · Cited by 97 · cited 1×
“ferrioxamine can block α-synuclein aggregation [78, 81] (Fig.”
Bovine adrenal tyrosine hydroxylase: purification and properties.
Hoeldtke, R. D., & Kaufman, S. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40366-8 · Cited by 91 · cited 1×
“For example, iron is a cofactor of the iron-containing tyrosine hydroxylase that catalyzes the hydroxylation of tyrosine to form dihydroxyphenylalanine (DOPA), the precursor of catecholamine neurotransmitters such as dopamine, adrenaline, and noradrenaline [24].”
BackgroundMoos, T., Skjoerringe, T., Gosk, S., & Morgan, E. H. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04023.x · Cited by 89 · cited 5×
“There is general agreement that the brain capillary endothelial cells (BCECs) absorb ironbound transferrin from the blood via transferrin receptor 1 (TfR1)-mediated endocytosis [6].”
BackgroundInfluentialPulliam, J. F., Jennings, C. D., Kryscio, R. J., Davis, D. G., Wilson, D., Montine, T. J., Schmitt, F. A., & Markesbery, W. R. (2003) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.10069 · Cited by 89 · cited 1×
“with disease in both cases compared to non-demented controls without pathology [58].”
ResultThe Ferroxidase Activity of Yeast Frataxin
Park, S., Gakh, O., Mooney, S. M., & Isaya, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206711200 · Cited by 88 · cited 1×
“Like H-ferritin, frataxin exerts ferroxidase activity to convert ferrous to ferric iron [190].”
BackgroundNew developments in understanding the etiology of Parkinson's disease and in its treatment
Lozano, A. M., Lang, A. E., Hutchison, W. D., & Dostrovsky, J. O. (1998) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(98)80122-0 · Cited by 87
RAURAMAA, R., VÄISÄNEN, S., MERCURI, M., RANKINEN, T., PENTTILÄ, I., & BOND, M. G. (1994) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060623 · Cited by 83
Transferrin gene expression and secretion by rat brain cells in vitro
De los Monteros, A. E., Kumar, S., Scully, S., Cole, R., & de Vellis, J. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490250416 · Cited by 80 · cited 1×
“Tf is supplied by the oligodendrocytes and choroids plexus epithelial cells for delivery of iron to neuronal cells and macro- and microglia [15].”
BackgroundIntravenous Iron Therapy as a Possible Risk Factor for Atherosclerosis in End-stage Renal Disease
Reis, K. A., Guz, G., Ozdemir, H., Erten, Y., Atalay, V., Bicik, Z., Ozkurt, Z. N., Bali, M., & Sindel, S. (2005) · International Heart Journal · doi:10.1536/ihj.46.255 · Cited by 79 · cited 1×
“In dialysis patients, the massive intravenous iron treatment correlates with the production of advanced oxidation protein products and with carotid intima media thickness, an early marker of the atherosclerotic process [162,163].”
BackgroundCorrelation of iron and zinc levels with lesion depth in newly formed atherosclerotic lesions
Minqin, R., Watt, F., Huat, B. T. K., & Halliwell, B. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01427-2 · Cited by 79 · cited 1×
“Interestingly, treatment of the rabbits with desferrioxamine, an iron chelator, caused inhibition of atherosclerotic plaque development and decreased the iron concentration within the lesion [156,157].”
BackgroundHe, Y., Janssen, W. G. M., & Morrison, J. H. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19981115)54:4<444::aid-jnr2>3.0.co;2-3 · Cited by 73
Moos, T., & Nielsen, T. R. (2006) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2006.08.003 · Cited by 72 · cited 5×
“There is general agreement that the brain capillary endothelial cells (BCECs) absorb ironbound transferrin from the blood via transferrin receptor 1 (TfR1)-mediated endocytosis [6].”
BackgroundInfluentialSengstock, G. J., Olanow, C. W., Dunn, A. J., Barone, S., & Arendash, G. W. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1187 · Cited by 72
Iron as catalyst for oxidative stress in the pathogenesis of Parkinson's disease?
Kienzl, E., Jellinger, K. A., Stachelberger, H., & Linert, W. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00458-0 · Cited by 70
Kraml, P. J., Klein, R. L., Huang, Y. Q., Nareika, A., & Lopes-Virella, M. F. (2005) · Metabolism · doi:10.1016/j.metabol.2004.10.012 · Cited by 69 · cited 1×
“induce macrophage scavenger receptor I expression in THP-1 mononuclear phagocytes [158].”
BackgroundGaly, B., Hölter, S. M., Klopstock, T., Ferring–Appel, D., Becker, L., Kaden, S., Wurst, W., Gröne, H., & Hentze, M. W. (2006) · Nature Genetics · doi:10.1038/ng0906-967 · Cited by 68 · cited 1×
“mouse lines await further clarification [180].”
Owen, A., Schapira, A. H. V., Jenner, P. G., & MARSDEN, C. D. (1997) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6846-2_14 · Cited by 67
Prevalence and Penetrance of HFE Mutations in 4865 Unselected Primary Care Patients
Phatak, P. D., Ryan, D. H., Cappuccio, J. D., Oakes, D., Braggins, C., Provenzano, K., Eberly, S. W., & Sham, R. L. (2002) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2002.0536 · Cited by 67
Iron accumulation in the substantia nigra of autosomal recessive juvenile parkinsonism (ARJP)
Takanashi, M., Mochizuki, H., Yokomizo, K., Hattori, N., Mori, H., Yamamura, Y., & Mizuno, Y. (2001) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(00)00050-x · Cited by 67
He, Y., Thong, P. S. P., Lee, T., Leong, S. K., Shi, C., Wong, P. T. ‐., Yuan, S. Y., & Watt, F. (1996) · Brain Research · doi:10.1016/0006-8993(96)00313-7 · Cited by 66
Pascazio, L., Bianco, F., Giorgini, A., Galli, G., Curri, G., & Panzetta, G. O. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90253-x · Cited by 65 · cited 1×
“For example, dialysis patients have a significantly higher incidence of atherosclerosis than normal controls, and cardiovascular disease is one of the most common causes of death [160].”
BackgroundIron Dysregulation in Friedreich Ataxia
Wilson, R. B. (2006) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2006.08.005 · Cited by 62
Evaluation of HFE (hemochromatosis) mutations as genetic modifiers in sporadic AD and MCI
Berlin, D., Chong, G., Chertkow, H. M., Bergman, H., Phillips, N. A., & Schipper, H. M. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.06.008 · Cited by 60
Iron requirements in erythropoietin therapy
Eschbach, J. W. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.09.005 · Cited by 57 · cited 1×
“To compensate, these patients are treated with recombinant erythropoietin together with intravenous iron sucrose to support erythropoiesis [161].”
BackgroundGALY, B., FERRING, D., BENESOVA, M., BENES, V., & HENTZE, M. W. (2004) · RNA · doi:10.1261/rna.7220704 · Cited by 56 · cited 1×
“While mice with a constitutive deletion of IRP-1 are healthy [178,179], mice with disruption of IRP-2 show a neurodegenerative disease characterized by a movement disorder with ataxia, bradikinesia, and tremor.”
BackgroundVlad, M., Caseanu, E., Uza, G., & Petrescu, M. (1994) · PubMed · Cited by 53
Detrimental Effects of Apolipoprotein E4: Potential Therapeutic Targets in Alzheimers Disease
Mahley, R., Huang, Y., & Weisgraber, K. (2007) · Current Alzheimer Research · doi:10.2174/156720507783018334 · Cited by 51 · cited 1×
“The apolipoprotein E ε4 (APOEε4) allele is such a genetic risk factor [64] and carriers of the ε4 allele show accelerated cognitive decline due to the allele’s cumulative impact on the Aβ and NFT biochemical pathways [65].”
BackgroundCombarros, O., García-Román, M., Fontalba, A., Fernández-Luna, J. L., Llorca, J., Infante, J., & Berciano, J. (2003) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000068480 · Cited by 49
Waalen, J., Felitti, V. J., Gelbart, T., Ho, N. J., & Beutler, E. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01249-4 · Cited by 47 · cited 1×
“Likewise, within 30,916 white adult individuals with compound heterozygosity (C282Y/H63D), a higher prevalence of coronary heart disease was detected [142].”
BackgroundThe activation of bovine pineal tryptophan 5‐monooxygenase
Ichiyama, A., Hori, S., Mashimo, Y., Nukiwa, T., & Makuuchi, H. (1974) · FEBS Letters · doi:10.1016/0014-5793(74)80900-2 · Cited by 43 · cited 1×
“Additionally, tryptophan hydroxylase contains iron to catalyze the first step of the conversion of tryptophan to serotonin [26].”
BackgroundSerum ferritin is not a risk factor for coronary artery disease in men and women aged ≥62 years
Aronow, W. S. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90684-5 · Cited by 42
Haemochromatosis gene mutations and risk of coronary artery disease
Battiloro, E., Ombres, D., Pascale, E., D’Ambrosio, E., Verna, R., & Arca, M. (2000) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200465 · Cited by 42
Elemental changes in atherosclerotic lesions using nuclear microscopy.
Thong, P. S. P., Selley, M. L., & Watt, F. (1996) · PubMed · Cited by 41
Candore, G., Licastro, F., Chiappelli, M., Franceschi, C., Lio, D., Balistreri, C. R., Piazza, G., Colonna‐Romano, G., Grimaldi, L. M., & Caruso, C. (2003) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(03)00031-9 · Cited by 40
Mutations in the Hemochromatosis Gene ( HFE ) and Stroke
Njajou, O. T., Hollander, M., Koudstaal, P. J., Albert Hofman, D., Witteman, J. C. M., Breteler, M. M. B., & van Duijn, C. M. (2002) · Stroke · doi:10.1161/01.str.0000029779.37078.c7 · Cited by 38 · cited 1×
“By contrast, several other studies failed to notice correlations between HFE mutations (C282Y and/or H63D) and stroke [144], myocardial infarction [145],”
ResultMacDonald, H. (1993) · Circulation · doi:10.1161/01.cir.87.6.2063 · Cited by 36 · cited 1×
“Some studies report that high ferritin levels (> 200 μg/ml), a commonly used biomarker for increased hepatic iron levels, is a risk factor for the development of coronary heart disease [129] or myocardial infarction, in particular in smokers and in subjects with diabetes or high serum cholesterol concentrations [130].”
BackgroundRecent Developments in Iron Chelation Therapy
Cario, H., Janka-Schaub, G. E., Janßen, G., Jarisch, A., Strauß, G., & KOHNE, E. (2007) · Klinische Pädiatrie · doi:10.1055/s-2007-973845 · Cited by 36
The Effect of Transferrin Polymorphisms on Iron Metabolism
Lee, P. L., Ho, N. J., Olson, R., & Beutler, E. (1999) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.1999.0267 · Cited by 35 · cited 2×
“Transferrin C2 is characterized by a mutation at aminoacid residue 570 (P570S) [66] that was previously identified with increased frequency in AD patients [67,68].”
BackgroundHereditary hemochromatosis genotypes and risk of ischemic stroke
Ellervik, C., Tybjærg‐Hansen, A., Appleyard, M., Sillesen, H. H., Boysen, G., & Nordestgaard, B. G. (2007) · Neurology · doi:10.1212/01.wnl.0000257814.77115.d6 · Cited by 35 · cited 1×
“A further Dutch study performed on 9,178 subjects that considered all HFE mutations revealed that only H63D/H63D homozygosity is strongly associated with ischemic cerebrovascular disease and ischemic stroke with a risk of 2% and 3%, respectively [143].”
BackgroundMovement disorders in the Hfe knockout mouse
Golub, M. S., Germann, S. L., Araiza, R. S., Reader, J. R., Griffey, S. M., & Kent Lloyd, K. C. (2005) · Nutritional Neuroscience · doi:10.1080/10284150500277685 · Cited by 27 · cited 1×
“Such a mechanism will protect the brain from systemic iron deficiency and iron overload consistent with the notion that iron overload conditions like hereditary haemochromatosis do not affect the brain iron content [22].”
BackgroundTransferrin C2 allele, haemochromatosis gene mutations, and risk for Alzheimer's disease
Lleo, A. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.6.820-a · Cited by 24 · cited 1×
“Several independent studies were unable to recognize C282Y and H63D mutations as a risk factor for AD [60].”
Preliminary demonstration of an allelic association of the IREB2 gene with Alzheimer's disease
Coon, K. D., Siegel, A. M., Yee, S. J., Dunckley, T. L., Mueller, C., Nagra, R. M., Tourtellotte, W. W., Reiman, E. M., Papassotiropoulos, A., Petersen, F. F., et al. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9301 · Cited by 22
Clinical penetrance of C282Y homozygous HFE haemochromatosis.
Rossi, E., & Jeffrey, G. P. (2004) · PubMed · Cited by 20
C282Y mutation in the HLA-H Gene is Not a Risk Factor for Patients with Myocardial Infarction
Annichino‐Bizzacchi, J. M., Saad, S. T. O., Arruda, V. R., Ramires, J. A. F., Siqueira, L. H., Chiaparini, L. C., & Mansur, A. D. P. (2000) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/204748730000700107 · Cited by 20 · cited 1×
“By contrast, several other studies failed to notice correlations between HFE mutations (C282Y and/or H63D) and stroke [144], myocardial infarction [145],”
ResultGenes and oxidative stress in parkinsonism: cDNA microarray studies.
Mandel, S. A., Grünblatt, E., Riederer, P., & Youdim, M. B. H. (2003) · PubMed · Cited by 19
Can Iron Chelators Influence the Progression of Atherosclerosis?
Marx, J. J. M., Kartikasari, A. E. R., & Georgiou, N. A. (2008) · Hemoglobin · doi:10.1080/03630260701726871 · Cited by 18 · cited 1×
“Furthermore, iron was suggested to modify the expression of transcription factors, cytokines, or growth factors that are involved in the formation of atherosclerotic lesions [154].”
BackgroundFriedman, A., & Gałązka-Friedman, J. (2001) · PubMed · Cited by 16
Iron stores and coronary artery disease
Pilote, L., Joseph, L., Bélisle, P., Robinson, K., Lente, F., & Tager, I. B. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00234-6 · Cited by 14
Iron and ischemic heart disease.
Giles, W. H., Anda, R. F., Williamson, D. F., Yip, R., & Marks, J. (1993) · Circulation · doi:10.1161/01.cir.87.6.2065 · Cited by 14 · cited 4×
“Furthermore, high ferritin levels correlate with high level of cholesterol LDL [131,132].”
BackgroundInfluentialStriatal Dopamine Dynamics Are Altered Following an Intranigral Infusion of Iron in Adult Rats
Lin, A. M. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(97)00398-5 · Cited by 14
Does serum ferritin correlate with coronary angiography findings?
Manfrói, W. C., Zago, A. J., Caramori, P., Cruz, R., Oliveira, J., Kirschnick, L., Ordovas, K. G., Candiago, R. H., Souza, J., Ribeiro, L. W., et al. (1999) · International Journal of Cardiology · doi:10.1016/s0167-5273(99)00020-0 · Cited by 10
Cited by
The role of iron in brain ageing and neurodegenerative disorders
Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R., & Zecca, L. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70117-6 · Cited by 1,819
Oxidative stress in Alzheimer’s disease
Chen, Z., & Zhong, C. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1423-y · Cited by 797
“Iron accumulation is also present in cells associated with neuritic plaques in AD([75]), which results in the increase of oxidative stress.”
BackgroundBioinorganic Chemistry of Alzheimer’s Disease
Kepp, K. P. (2012) · Chemical Reviews · doi:10.1021/cr300009x · Cited by 672
Basic mechanisms of neurodegeneration: a critical update
Jellinger, K. A. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01010.x · Cited by 596
“Conditions such as neuroferritinopathy [217] and Friedreich ataxia are associated with mutations in genes that encode proteins involved in iron metabolism [218], inducing OS and cell death [441] the brain ages, iron accumulates in regions that are affected by AD and PD [219], and dopamine (DA) complexes of iron are im…”
BackgroundQuantitative MR Imaging of Brain Iron: A Postmortem Validation Study
Langkammer, C., Krebs, N., Goessler, W., Scheurer, E., Ebner, F., Yen, K., Fazekas, F., & Ropele, S. (2010) · Radiology · doi:10.1148/radiol.10100495 · Cited by 507
Metadata
- Authors
- Altamura, S., & Muckenthaler, M. U.
- Affiliations
- University Hospital Heidelberg (DE)
- Corresponding author
- Muckenthaler, Martina U.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2009-04-17
- Volume
- 16
- Issue
- 4
- Pages
- 879-895
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1785761853
- Cited by
- 369
- References
- 190
- Citations by year
- 2026: 5 · 2025: 15 · 2024: 13 · 2023: 17 · 2022: 26 · 2021: 22 · 2020: 25 · 2019: 28 · 2018: 26 · 2017: 22 · 2016: 22 · 2015: 16 · 2014: 30 · 2013: 23 · 2012: 19
- FWCI
- 17.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Baden-Württemberg Stiftung
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Keywords
- iron toxicity, brain iron accumulation
- MeSH terms
- Aging, Alzheimer Disease, Animals, Brain, Humans, Iron, Parkinson Disease, Oxidative Stress, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.